Literature DB >> 23906741

Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity.

Dennis A Bente1, Naomi L Forrester, Douglas M Watts, Alexander J McAuley, Chris A Whitehouse, Mike Bray.   

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is the most important tick-borne viral disease of humans, causing sporadic cases or outbreaks of severe illness across a huge geographic area, from western China to the Middle East and southeastern Europe and throughout most of Africa. CCHFV is maintained in vertical and horizontal transmission cycles involving ixodid ticks and a variety of wild and domestic vertebrates, which do not show signs of illness. The virus circulates in a number of tick genera, but Hyalomma ticks are the principal source of human infection, probably because both immature and adult forms actively seek hosts for the blood meals required at each stage of maturation. CCHF occurs most frequently among agricultural workers following the bite of an infected tick, and to a lesser extent among slaughterhouse workers exposed to the blood and tissues of infected livestock and medical personnel through contact with the body fluids of infected patients. CCHFV is the most genetically diverse of the arboviruses, with nucleotide sequence differences among isolates ranging from 20% for the viral S segment to 31% for the M segment. Viruses with diverse sequences can be found within the same geographic area, while closely related viruses have been isolated in far distant regions, suggesting that widespread dispersion of CCHFV has occurred at times in the past, possibly by ticks carried on migratory birds or through the international livestock trade. Reassortment among genome segments during co-infection of ticks or vertebrates appears to have played an important role in generating diversity, and represents a potential future source of novel viruses. In this article, we first review current knowledge of CCHFV, summarizing its molecular biology, maintenance and transmission, epidemiology and geographic range. We also include an extensive discussion of CCHFV genetic diversity, including maps of the range of the virus with superimposed phylogenetic trees. We then review the features of CCHF, including the clinical syndrome, diagnosis, treatment, pathogenesis, vaccine development and laboratory animal models of CCHF. The paper ends with a discussion of the possible future geographic range of the virus. For the benefit of researchers, we include a Supplementary Table listing all published reports of CCHF cases and outbreaks in the English-language literature, plus some principal articles in other languages, with total case numbers, case fatality rates and all CCHFV strains on GenBank.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arbovirus; Bunyavirus; Crimean–Congo hemorrhagic fever virus; Nairovirus; Tick-borne virus; Viral hemorrhagic fever

Mesh:

Year:  2013        PMID: 23906741     DOI: 10.1016/j.antiviral.2013.07.006

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  218 in total

Review 1.  Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases.

Authors:  Rita M Meganck; Ralph S Baric
Journal:  Nat Med       Date:  2021-03-15       Impact factor: 53.440

2.  Evaluation of cases with a preliminary diagnosis of Crimean- Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey.

Authors:  Hüseyin Can Hekimoğlu; Neşe Ateş Demirci
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

3.  Francisella-Like Endosymbionts and Rickettsia Species in Local and Imported Hyalomma Ticks.

Authors:  Tal Azagi; Eyal Klement; Gidon Perlman; Yaniv Lustig; Kosta Y Mumcuoglu; Dmitry A Apanaskevich; Yuval Gottlieb
Journal:  Appl Environ Microbiol       Date:  2017-08-31       Impact factor: 4.792

4.  Crimean-Congo Hemorrhagic Fever in Spain - New Arrival or Silent Resident?

Authors:  Jessica R Spengler; Dennis A Bente
Journal:  N Engl J Med       Date:  2017-07-13       Impact factor: 91.245

Review 5.  Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.

Authors:  Brian B Gowen; Brady T Hickerson
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 3.422

Review 6.  The role of ticks in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus: A review of published field and laboratory studies.

Authors:  Aysen Gargili; Agustin Estrada-Peña; Jessica R Spengler; Alexander Lukashev; Patricia A Nuttall; Dennis A Bente
Journal:  Antiviral Res       Date:  2017-06-01       Impact factor: 5.970

Review 7.  An Emerging Biothreat: Crimean-Congo Hemorrhagic Fever Virus in Southern and Western Asia.

Authors:  Paul W Blair; Jens H Kuhn; David B Pecor; Dmitry A Apanaskevich; Mark G Kortepeter; Anthony P Cardile; Aileen Polanco Ramos; Maryam Keshtkar-Jahromi
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

8.  Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine.

Authors:  Jessica R Spengler; Stephen R Welch; Florine E M Scholte; JoAnn D Coleman-McCray; Jessica R Harmon; Stuart T Nichol; Éric Bergeron; Christina F Spiropoulou
Journal:  Antiviral Res       Date:  2019-08-01       Impact factor: 5.970

9.  The Non-structural Protein of Crimean-Congo Hemorrhagic Fever Virus Disrupts the Mitochondrial Membrane Potential and Induces Apoptosis.

Authors:  Bhaskar Barnwal; Helen Karlberg; Ali Mirazimi; Yee-Joo Tan
Journal:  J Biol Chem       Date:  2015-11-16       Impact factor: 5.157

10.  Fluorometric CCHFV OTU protease assay with potent inhibitors.

Authors:  Fatih Kocabas; Galip S Aslan
Journal:  Virus Genes       Date:  2015-07-09       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.